Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Preferred Stock Liabilities (2016)

Historic Preferred Stock Liabilities for Armata Pharmaceuticals (ARMP) over the last 4 years, with Q1 2016 value amounting to $13.6 million.

  • Armata Pharmaceuticals' Preferred Stock Liabilities rose 48483.68% to $13.6 million in Q1 2016 from the same period last year, while for Mar 2016 it was $13.6 million, marking a year-over-year increase of 48483.68%. This contributed to the annual value of $11.9 million for FY2015, which is 49748.74% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Preferred Stock Liabilities stood at $13.6 million for Q1 2016, which was up 48483.68% from $11.9 million recorded in Q4 2015.
  • In the past 5 years, Armata Pharmaceuticals' Preferred Stock Liabilities ranged from a high of $46.3 million in Q1 2014 and a low of $2.0 million during Q4 2014
  • For the 4-year period, Armata Pharmaceuticals' Preferred Stock Liabilities averaged around $17.9 million, with its median value being $12.8 million (2015).
  • In the last 5 years, Armata Pharmaceuticals' Preferred Stock Liabilities plummeted by 9512.15% in 2014 and then soared by 49748.74% in 2015.
  • Quarter analysis of 4 years shows Armata Pharmaceuticals' Preferred Stock Liabilities stood at $40.8 million in 2013, then tumbled by 95.12% to $2.0 million in 2014, then surged by 497.49% to $11.9 million in 2015, then grew by 14.51% to $13.6 million in 2016.
  • Its last three reported values are $13.6 million in Q1 2016, $11.9 million for Q4 2015, and $10.9 million during Q3 2015.